LITTLE FALLS, N.J., May 28 -- Intravenous clot-busting therapy with tissue plasminogen activator (tPA) should be administered up to 4.5 hours from stroke onset in eligible patients, according to a science advisory from the American Heart Association/American Stroke Association.
